Allogene Therapeutics Inc. (NASDAQ: ALLO) announced that regulatory authorities in South Korea and Australia have approved the expansion of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE